EXPLORE WHAT’S NEW

Arrakis in the News

September 6, 2022
BioPharma Dive
Drugging RNA with pills: small molecules for a big frontier

April 8, 2022
Chemical & Engineering News
Jennifer Petter Wants to Interfere with RNA to Discover New Drug Targets

January 13, 2022
STAT The Readout Loud Podcast

#JPM22 in review, Biogen’s worsening fortunes, & the future of RNA drugs

Michael Gilman

January 11, 2022
BioCentury
Amgen, Arrakis taking the logic of PROTACs to RNA degraders

January 11, 2022
Fierce Biotech
Amgen teams up with Arrakis to destroy disease-causing RNA in $75M research deal

December 7, 2021
Fierce Biotech
‘Don’t check yourself when you come to work’: Being openly LGBTQ+ in a scientist-led industry

November 1, 2021
Genetic Engineering News
Undruggable No Longer

August 2, 2021
Business Insider
Meet the 24 biotech startups that top VCs say are poised to take off in the next 12 months

June 14, 2021
Timmerman Report
Biotech Pride: 19 Industry Leaders Who Identify as LGBTQ
Jennifer Petter

May 26, 2021
Endpoints News
Legacies: 60 biopharma pioneers over 60 who helped birth a tech revolution in the making
Michael Gilman

February 22, 2021
Chemistry World
Drugging RNA

December 10, 2020
Endpoints News
Special report: Twenty extraordinary women blazing trails in biopharma R&D — Covid-19 and beyond
Jennifer Petter

September 29, 2020
Timmerman Report

August 17, 2020
Wall Street Journal
Companies Strain to Outdo Each Other with Work-from-Home Perks (Think Ukuleles)

May 5, 2020
BioCentury

April 8, 2020
BioCentury
RNA-targeting small molecule play Arrakis taps Roche as first pharma partner

April 8, 2020
FierceBiotech
Arrakis, Roche team up on RNA-targeting drugs in $190M deal

April 8, 2020
Xconomy
Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics

April 8, 2020
BioPharma Dive
Amid a pandemic, Roche bets $190M on Arrakis and drugging RNA

April 18, 2019
STAT – The Readout Loud biotech podcast
Drugging the undruggable
Biotech entrepreneur Michael Gilman dials in to talk about his company’s efforts to craft pills that can do what has thus far proved impossible.

October 2, 2018
FierceBiotech
FierceBiotech’s 2018 Fierce 15: Arrakis – Mining the RNA world for new medicines

January 10, 2018
Endpoints News
The Endpoints 11: A group of disruptive upstarts on a do-or-die mission to launch new meds

November 28, 2017
Nature Reviews Drug Discovery
Small molecules against RNA targets attract big backers

November 6, 2017
C&EN (Chemical & Engineering News)
Arrakis is selected as one of C&EN’s Ten Start-Ups to Watch: “Meet the master builders behind chemistry’s most intriguing young companies.”
Ten Start-Ups to Watch

August 8, 2017
Xconomy
Arrakis is selected as a finalist for the Xconomy Awards as Big Idea of the year. Winners will be announced on September 26.
Xconomy Award Finalists

March 2, 2017
BioCentury Innovations
RNA, Meet Small Molecules

February 28, 2017
BioWorld Today
Gilman-led Arrakis Lands $38M Series A Round

February 27, 2017
Xconomy
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills

February 27, 2017
Endpoints News
Going Big: Biotech Vets Blast off with Arrakis on a New Journey of RNA Exploration

February 27, 2017
Fierce Biotech
Pfizer, Celgene-Backed Upstart Arrakis Hopes to Mine RNA Spice